Wave life sciences ltd. (WVE)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Cash flows from operating activities
Net loss

-47,493

-56,770

-50,726

-41,942

-44,200

-37,887

-37,631

-35,894

-35,241

-30,793

-25,494

-24,597

-21,096

-18,713

-17,535

-11,565

-7,847

-7,099

-4,936

-3,700

-3,465

Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of lease incentive obligation

-

-

-

-

-

289

232

162

107

77

65

49

17

-

-

-

-

-

-

-

-

Amortization of right-of-use assets

442

426

411

395

381

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation of property and equipment

2,039

2,016

1,947

1,854

1,783

1,733

1,458

1,234

1,175

934

595

356

315

259

188

184

153

132

284

89

89

Share-based compensation expense

3,999

4,987

5,020

5,157

4,345

4,011

3,610

3,545

4,430

3,177

3,000

2,967

2,999

2,528

2,183

1,270

866

814

718

646

1,846

Net loss on disposal of property and equipment

-

-

-

-

-

0

10

-41

-13

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

73

230

283

387

387

1,023

1,153

1,031

194

117

118

136

92

-1

27

-30

Deferred income taxes

-

-

-

-

-

-

-

-

-

4

772

325

-193

-876

135

48

-5

-146

83

49

50

Changes in operating assets and liabilities:
Accounts receivable

-20,000

-

-

-

-

0

-5,000

65,000

-1,000

-

-

-

-

-

-

-

-

-

7

-231

31

Prepaid expenses

373

-

-

-

1,090

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

-

1,429

3,773

485

-

1,544

530

1,813

871

-1,603

1,655

414

-170

22

-32

50

Other assets

1,983

-

-

-

2,124

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current assets

-

-

-

-

-

-

5

-1

11

-

-

-

-

-

-

-

53

-

-

-

-

Accounts payable

7,336

-10,968

8,431

-1,743

783

2,135

3,113

-702

390

3,268

-1,061

668

1,017

1,470

716

1,479

-296

-816

751

1,464

249

Accrued expenses and other current liabilities

-5,191

2,446

2,106

3,363

-6,467

5,217

1,416

1,772

-2,541

2,652

1,734

701

-537

-188

1,276

879

329

340

282

-104

-251

Deferred revenue

-4,161

-2,400

-2,929

-7,628

-3,026

-3,622

-4,492

170,121

-1,422

-98

-1,315

-1,097

-383

-

-

-

-

0

0

-126

-26

Operating lease liabilities

-765

-750

-712

-691

-663

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current liabilities

-100

-72

-104

-142

-103

647

-38

-72

-14

598

-1,049

15

1,259

877

-4

-4

-5

-

-

-

-

Net cash used in operating activities

-26,250

-61,240

-43,681

-32,929

-50,381

-32,820

-29,010

71,394

-32,426

-22,754

-23,411

-20,088

-17,418

-13,347

-11,832

390

-7,136

-6,668

-2,848

-1,392

-1,619

Increase in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,000

55

Purchases of property and equipment

580

1,346

465

1,599

508

3,463

3,389

1,922

1,164

4,079

5,606

5,567

3,635

2,729

1,275

878

685

970

509

361

17

Net cash used in investing activities

-580

-1,346

-465

-1,599

-508

-3,463

-3,389

-1,922

-1,164

-4,079

-5,606

-5,567

-3,635

-2,729

-1,275

-874

-685

-970

-509

-1,358

-72

Cash flows from financing activities
Payments on capital lease obligation

-

-

-

-

-

0

0

0

16

15

16

15

16

15

16

15

16

-

-

-

-

Proceeds from the exercise of share options

10

757

253

116

1,481

646

1,351

1,560

1,553

604

80

37

206

-

-

-

-

-

-

-

-

Net cash provided by financing activities

614

757

253

-157

163,546

646

1,351

61,560

1,537

589

59

93,536

190

15

184

28,938

-16

102,736

61,211

15

11,631

Effect of foreign exchange rates on cash, cash equivalents and restricted cash

6

-15

2

30

97

-28

110

-88

43

285

30

31

57

-115

173

-86

14

82

407

-447

-27

Net increase (decrease) in cash, cash equivalents and restricted cash

-26,210

-61,844

-43,891

-34,655

112,754

-35,665

-30,938

130,944

-32,010

-25,959

-28,928

67,912

-20,806

-16,176

-12,750

28,368

-7,823

95,180

58,261

-3,182

9,913

Supplemental disclosure of cash flow information:
Deferred follow-on offering costs in accounts payable and accrued expenses at period end

-

-

-

-

280

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for taxes, net of refunds

-

-

-

-

-

-

-

-

-

-

11

182

18

-

-

-

-

-

-

-

-

Property and equipment purchases in accounts payable and accrued expenses at period end

-

-

-

-

-

-

-

-

-

-

-1,568

11

2,976

-

556

854

185

-

-

-

-

Tenant improvements paid for by the landlord during the period

-

-

-

-

-

-

-

-

-

-

408

1,284

1,082

-

-

-

-

-

-

-

-

At-The-Market Equity Program [Member]
Proceeds from issuance of ordinary shares, net of offering costs

604

0

0

-273

162,065

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

11,631